News story

Dr Linda Harris to join drugs advisory council

This news article was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government

A new member has been appointed to the Advisory Council on the Misuse of Drugs (ACMD), the minister for crime prevention Baroness Browning announced today.

The new appointee is Dr Linda Harris, CEO and clinical director of Spectrum community health community interest company. She is also clinical director of the Royal College of General Practitioners substance misuse and associated health unit.

Valuable role

Baroness Browning said: ‘I welcome the appointment of Dr Harris to the ACMD. Her expertise and experience in the provision of drug treatment across the community will be of immense value.

‘This government recognises the wide range of expertise in the ACMD and the valuable role it has to play in informing government drug policy.’

The appointment will be for a period of three years and is unpaid.

Established in 1971

The ACMD was established under the Misuse of Drugs Act 1971.

The independent panel keep drugs misuse in the UK under review and advise government on its findings.

Professor Les Iversen has been the ACMD chairperson since January 2010.